Brian T Brunelli, MD
Neurology · Santa Cruz
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 8
Offices
8 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Dominican Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Brunelli’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A88363 · Current
Licensed to practise in California · since 2004 · expires 2028-06-30 · Tufts University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Dominican HospitalSanta Cruz, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 68% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Postoperative sepsis rate: 11.66 (8.02 to 15.3) · 412 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.168, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.169, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.489, Oct 2024 – Sep 2025
See every measure and the patient survey for Dominican Hospital
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative sepsis rateComplications and deaths | 11.66 (8.02 to 15.3) · 412 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.168 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.169 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.489 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0.06 to 1.95) · 1,248 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.14 (0.85 to 1.43) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 134.37 (94.33 to 174.41) · 132 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 54 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 137 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12 · 228 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.5 · 534 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.8 · 491 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 278 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 2,973 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.14 (0 to 0.34) · 7,510 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,695 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.42 (1.44 to 5.4) · 1,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.26 (0 to 2.76) · 436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.85 (0.4 to 3.29) · 1,474 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.73 (3 to 14.46) · 437 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.58 (0.13 to 3.03) · 343 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.17) · 6,336 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.615 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.937 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 212 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 505 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 45 · 237 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.5 · 594 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.9 · 510 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 473 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.4 to 7.8) · 126 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13 (9.4 to 17.7) · 126 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 12.7 · 43 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 143 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.1 (9.4 to 15.4) · 1,585 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 390 cases | No different | Jan 2024 – Dec 2024 |
What patients said (774 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 77% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 32% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$278,005
Medicare paid this office $278,005 for 640 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Botox | 58 | $132,320 | None |
| Return visit (30+ min) | 267 | $38,235 | $101 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 41 | $15,442 | $126 |
| New patient visit (45+ min) | 84 | $11,156 | $133 |
| Long return visit (40+ min) | 62 | $9,416 | $147 |
See all 14 services
| Botox | 58 | $132,320 | None |
| Return visit (30+ min) | 267 | $38,235 | $101 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 41 | $15,442 | $126 |
| New patient visit (45+ min) | 84 | $11,156 | $133 |
| Long return visit (40+ min) | 62 | $9,416 | $147 |
| Short return visit (20+ min) | 104 | $8,414 | $67 |
| New patient visit (60+ min) | 45 | $8,394 | $187 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 55 | $7,616 | $138 |
| Nerve test | 46 | $7,105 | $151 |
| Muscle electrical test | 64 | $7,083 | $83 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 300 | $5,656 | $13 |
| Nerve test | 26 | $4,559 | $175 |
| Nerve test | 14 | $1,372 | $98 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,342 | $64 |
Procedures Medicare counted
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
640 Original Medicare patients in 2024. Average age 75 · Under 65 10% · 85 and older 13% · Women 57% · Also on Medicaid 17% · Health risk score 1.24. At or below the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 62% · Depression 29% · Chronic kidney disease 23% · Diabetes 22% · Coronary heart disease 22% · Atrial fibrillation 19% · Cancer 17% · Heart failure 14% · Stroke 14% · Dementia 13% · COPD 9%.
The office billed $1,032,396, Medicare allowed $360,027 and paid $278,005; for 28,835 services of 43 kinds; $132,351 of it was for drugs given in the office and $145,655 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 640 | 28,835 | 75 | 1.24 | $1,032,396 | $278,005 |
| 2023 | 657 | 20,015 | 74 | 1.16 | $809,064 | $225,458 |
| 2022 | 693 | 21,756 | 74 | 1.18 | $866,274 | $247,288 |
| 2021 | 635 | 24,212 | 74 | 1.22 | $825,817 | $251,033 |
| 2020 | 540 | 17,206 | 73 | 1.29 | $632,987 | $185,346 |
| 2019 | 698 | 23,254 | 73 | 1.35 | $834,426 | $235,232 |
| 2018 | 646 | 16,026 | 73 | 1.28 | $656,477 | $183,186 |
| 2017 | 598 | 12,257 | 72 | 1.28 | $572,561 | $159,205 |
| 2016 | 591 | 12,923 | 73 | 1.31 | $581,928 | $156,149 |
| 2015 | 582 | 9,188 | 73 | 1.26 | $494,585 | $138,554 |
| 2014 | 571 | 8,898 | 73 | 1.20 | $509,800 | $134,572 |
| 2013 | 533 | 5,543 | 73 | 1.25 | $413,480 | $107,186 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Botox | 45 | $90,765 | None |
| Return visit (30+ min) | 264 | $36,759 | $101 |
| New patient visit (45+ min) | 124 | $16,154 | $130 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 30 | $12,106 | $130 |
| Short return visit (20+ min) | 119 | $9,663 | $68 |
| Nerve test | 57 | $8,707 | $148 |
| Muscle electrical test | 69 | $7,281 | $88 |
| New patient visit (60+ min) | 42 | $7,222 | $172 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 48 | $6,705 | $140 |
| Long return visit (40+ min) | 46 | $6,459 | $137 |
| Nerve test | 24 | $4,267 | $178 |
| Nerve test | 18 | $2,143 | $119 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $1,853 | $66 |
2022: 16 services
| Botox | 47 | $97,378 | None |
| Return visit (30+ min) | 265 | $36,925 | $103 |
| New patient visit (45+ min) | 130 | $17,259 | $133 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 33 | $13,642 | $135 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 72 | $11,958 | $162 |
| Short return visit (20+ min) | 126 | $10,247 | $67 |
| New patient visit (60+ min) | 44 | $8,467 | $192 |
| Muscle electrical test | 72 | $7,488 | $91 |
| Long return visit (40+ min) | 41 | $6,590 | $157 |
| Nerve test | 39 | $6,231 | $160 |
| Nerve test | 30 | $5,536 | $185 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $3,158 | $61 |
| Nerve test | 22 | $2,164 | $98 |
| Nerve test | 11 | $1,411 | $128 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,296 | $86 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 19 | $692 | $33 |
2021: 13 services
| Botox | 51 | $110,041 | None |
| Return visit (30+ min) | 229 | $33,744 | $106 |
| New patient visit (45+ min) | 130 | $18,518 | $142 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 37 | $12,970 | $134 |
| Short return visit (20+ min) | 141 | $12,713 | $73 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 50 | $8,716 | $171 |
| Nerve test | 45 | $7,634 | $166 |
| Long return visit (40+ min) | 43 | $6,403 | $142 |
| New patient visit (60+ min) | 33 | $5,754 | $174 |
| Muscle electrical test | 48 | $5,033 | $95 |
| Nerve test | 23 | $4,753 | $207 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $2,032 | $62 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 24 | $1,216 | $33 |
2020: 14 services
| Botox | 36 | $77,276 | None |
| Return visit (30+ min) | 159 | $17,765 | $86 |
| New patient visit (60+ min) | 73 | $12,940 | $177 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 58 | $10,346 | $175 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 27 | $9,603 | $128 |
| New patient visit (45+ min) | 69 | $8,962 | $130 |
| Short return visit (20+ min) | 114 | $7,295 | $54 |
| Nerve test | 34 | $5,941 | $170 |
| Long return visit (40+ min) | 50 | $5,848 | $115 |
| Muscle electrical test | 46 | $4,912 | $89 |
| Nerve test | 22 | $4,499 | $204 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $3,434 | $64 |
| Nerve test | 11 | $1,337 | $122 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 32 | $1,329 | $35 |
2019: 15 services
| Botox | 45 | $103,842 | None |
| Return visit (30+ min) | 209 | $21,245 | $84 |
| Short return visit (20+ min) | 198 | $14,658 | $59 |
| New patient visit (45+ min) | 110 | $14,521 | $132 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 68 | $11,635 | $171 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 31 | $11,591 | $125 |
| New patient visit (60+ min) | 60 | $10,231 | $171 |
| Nerve test | 46 | $7,593 | $165 |
| Nerve test | 29 | $5,859 | $202 |
| Muscle electrical test | 57 | $5,693 | $85 |
| Long return visit (40+ min) | 47 | $5,506 | $112 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $2,031 | $62 |
| Nerve test | 13 | $1,452 | $112 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 28 | $1,195 | $33 |
| New patient visit (30+ min) | 11 | $1,029 | $94 |
2018: 14 services
| Botox | 31 | $71,428 | None |
| New patient visit (45+ min) | 155 | $19,818 | $128 |
| Return visit (30+ min) | 162 | $15,823 | $85 |
| Short return visit (20+ min) | 181 | $13,371 | $54 |
| New patient visit (60+ min) | 78 | $12,578 | $161 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 54 | $9,048 | $165 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 22 | $7,972 | $117 |
| Nerve test | 37 | $6,229 | $164 |
| Long return visit (40+ min) | 42 | $4,890 | $114 |
| Muscle electrical test | 38 | $3,689 | $77 |
| Nerve test | 19 | $3,623 | $191 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,501 | $60 |
| New patient visit (30+ min) | 12 | $1,031 | $86 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $741 | $32 |
2017: 13 services
| Botox | 24 | $51,888 | None |
| New patient visit (45+ min) | 130 | $16,743 | $129 |
| Return visit (30+ min) | 149 | $14,938 | $85 |
| Short return visit (20+ min) | 181 | $14,151 | $56 |
| New patient visit (60+ min) | 84 | $13,864 | $165 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 56 | $9,026 | $161 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 17 | $5,839 | $114 |
| Nerve test | 28 | $5,559 | $199 |
| Nerve test | 31 | $5,156 | $161 |
| Long return visit (40+ min) | 32 | $3,715 | $116 |
| Muscle electrical test | 36 | $3,647 | $78 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $2,123 | $59 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 20 | $894 | $31 |
2016: 15 services
| Botox | 27 | $53,485 | None |
| New patient visit (45+ min) | 121 | $14,965 | $124 |
| New patient visit (60+ min) | 81 | $12,852 | $159 |
| Return visit (30+ min) | 142 | $12,819 | $80 |
| Short return visit (20+ min) | 161 | $11,495 | $52 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 68 | $11,067 | $160 |
| Nerve test | 40 | $6,308 | $158 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 19 | $6,124 | $111 |
| Nerve test | 28 | $5,095 | $182 |
| Long return visit (40+ min) | 33 | $3,251 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $2,455 | $58 |
| Muscle electrical test | 28 | $2,433 | $74 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 35 | $1,942 | $32 |
| Nerve test | 14 | $1,449 | $103 |
| New patient visit (30+ min) | 13 | $1,046 | $80 |
2015: 15 services
| Botox | 23 | $35,808 | None |
| New patient visit (45+ min) | 127 | $17,036 | $134 |
| Short return visit (20+ min) | 184 | $14,153 | $55 |
| Return visit (30+ min) | 131 | $12,663 | $84 |
| New patient visit (60+ min) | 74 | $12,320 | $166 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 58 | $9,772 | $168 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 17 | $5,895 | $123 |
| Nerve test | 32 | $5,221 | $163 |
| Long return visit (40+ min) | 34 | $4,130 | $118 |
| Nerve test | 15 | $3,046 | $203 |
| Muscle electrical test | 30 | $2,967 | $80 |
| Nerve test | 22 | $2,856 | $130 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $2,223 | $62 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 19 | $937 | $33 |
| New patient visit (30+ min) | 11 | $932 | $85 |
2014: 14 services
| Botox | 20 | $32,202 | None |
| New patient visit (45+ min) | 116 | $14,578 | $126 |
| New patient visit (60+ min) | 91 | $14,516 | $160 |
| Return visit (30+ min) | 147 | $14,422 | $82 |
| Short return visit (20+ min) | 199 | $14,384 | $51 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 53 | $8,589 | $159 |
| Nerve test | 34 | $5,397 | $150 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 16 | $4,641 | $113 |
| Long return visit (40+ min) | 32 | $3,543 | $98 |
| Muscle electrical test | 31 | $2,976 | $76 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $2,617 | $58 |
| Nerve test | 20 | $2,336 | $111 |
| Nerve test | 11 | $1,760 | $160 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 23 | $1,011 | $32 |
2013: 12 services
| Botox | 16 | $18,949 | None |
| Short return visit (20+ min) | 213 | $17,489 | $52 |
| New patient visit (45+ min) | 126 | $15,699 | $125 |
| Return visit (30+ min) | 121 | $11,573 | $77 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 60 | $9,508 | $156 |
| New patient visit (60+ min) | 47 | $7,201 | $153 |
| Long return visit (40+ min) | 34 | $3,824 | $112 |
| Nerve test | 32 | $3,644 | $114 |
| Nerve test | 18 | $2,569 | $143 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $2,479 | $56 |
| Muscle electrical test | 26 | $2,262 | $71 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 27 | $1,102 | $31 |
Medicaid work
$22,566 in 2024
Medicaid paid $22,566 for 47 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Botox | 35 | $21,997 |
| Return visit (30+ min) | 12 | $570 |
| 2024 | 47 | 2 | 13 | $22,566 |
| 2023 | 59 | 2 | 21 | $3,779 |
| 2022 | 37 | 1 | 13 | $2,370 |
| 2021 | 70 | 2 | 18 | $3,996 |
| 2020 | 16 | 1 | 16 | $1,020 |
| 2019 | 28 | 2 | 13 | $1,104 |
| 2018 | 26 | 1 | 13 | $551 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 38 | $2,694 |
| Return visit (30+ min) | 21 | $1,085 |
2022
| Return visit (30+ min) | 37 | $2,370 |
2021
| Return visit (30+ min) | 42 | $2,503 |
| Short return visit (20+ min) | 28 | $1,493 |
2020
| Return visit (30+ min) | 16 | $1,020 |
2019
| Return visit (30+ min) | 12 | $798 |
| Short return visit (20+ min) | 16 | $306 |
2018
| Short return visit (20+ min) | 26 | $551 |
Drugs they prescribed that Part D paid
$912,513
Pharmacies billed $912,513 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
2,568 generic and 387 brand-name prescriptions · $912,513 in drug cost · 42 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gamunex-C | Immune globulin | 49 | $156,262 | $3,189 |
| Nurtec Odt | None | 59 | $111,063 | $1,882 |
| Avonex (4 Pack) | None | 12 | $97,599 | $8,133 |
| Aimovig | Migraine | 94 | $84,984 | $904 |
| Copaxone | None | 11 | $78,279 | $7,116 |
See all 65 drugs
| Gamunex-C | Immune globulin | 49 | $156,262 | $3,189 |
| Nurtec Odt | None | 59 | $111,063 | $1,882 |
| Avonex (4 Pack) | None | 12 | $97,599 | $8,133 |
| Aimovig | Migraine | 94 | $84,984 | $904 |
| Copaxone | None | 11 | $78,279 | $7,116 |
| Qulipta | None | 25 | $55,621 | $2,225 |
| Rytary | Parkinson's | 27 | $39,183 | $1,451 |
| Ubrelvy | None | 26 | $33,830 | $1,301 |
| Emgality | Migraine | 20 | $14,988 | $749 |
| Neupro | None | 14 | $14,259 | $1,019 |
| Emgality | Migraine | 14 | $10,677 | $763 |
| Levetiracetam | None | 226 | $9,871 | $44 |
| Carbidopa-Levodopa | None | 227 | $8,976 | $40 |
| Carbidopa | None | 11 | $7,780 | $707 |
| Oxcarbazepine | None | 25 | $5,714 | $229 |
| Gabapentin | None | 248 | $5,427 | $22 |
| Clorazepate Dipotassium | None | 16 | $5,204 | $325 |
| Dilantin | None | 15 | $5,068 | $338 |
| Dilantin | None | 12 | $3,951 | $329 |
| Lacosamide | None | 26 | $3,805 | $146 |
| Sumatriptan | None | 122 | $3,552 | $29 |
| Divalproex | None | 52 | $3,336 | $64 |
| Propranolol | None | 116 | $3,283 | $28 |
| Topiramate | None | 27 | $3,101 | $115 |
| Donepezil | None | 222 | $2,706 | $12 |
| Memantine | None | 82 | $2,599 | $32 |
| Carbamazepine | None | 46 | $2,494 | $54 |
| Duloxetine | None | 37 | $2,083 | $56 |
| Rivastigmine | None | 30 | $2,011 | $67 |
| Dalfampridine Er | None | 25 | $1,732 | $69 |
| Ropinirole | None | 32 | $1,727 | $54 |
| Propranolol Hcl Er | None | 48 | $1,623 | $34 |
| Baclofen | None | 34 | $1,546 | $45 |
| Mycophenolate Mofetil | None | 13 | $1,390 | $107 |
| Carbamazepine Er | None | 14 | $1,387 | $99 |
| Amantadine | None | 27 | $1,329 | $49 |
| Azathioprine | None | 12 | $1,236 | $103 |
| Divalproex Sodium Er | None | 13 | $1,160 | $89 |
| Primidone | None | 24 | $1,066 | $44 |
| Donepezil Hcl Odt | None | 30 | $1,032 | $34 |
| Naratriptan | None | 15 | $1,001 | $67 |
| Lamotrigine | None | 50 | $934 | $19 |
| Quetiapine | None | 42 | $863 | $21 |
| Zonisamide | None | 13 | $853 | $66 |
| Escitalopram | None | 61 | $663 | $11 |
| Pregabalin | None | 17 | $540 | $32 |
| Rizatriptan | None | 26 | $492 | $19 |
| Clonazepam | None | 36 | $468 | $13 |
| Oxybutynin Chloride Er | None | 12 | $361 | $30 |
| Indomethacin | None | 20 | $324 | $16 |
| Midodrine | None | 14 | $312 | $22 |
| Metoprolol | None | 11 | $276 | $25 |
| Prednisone | None | 27 | $239 | $9 |
| Atorvastatin | None | 12 | $194 | $16 |
| Celecoxib | None | 13 | $194 | $15 |
| Trihexyphenidyl | None | 16 | $175 | $11 |
| Cyclobenzaprine | None | 14 | $166 | $12 |
| Lorazepam | None | 59 | $146 | $2 |
| Eletriptan Hbr | None | 11 | $123 | $11 |
| Ondansetron Odt | None | 14 | $117 | $8 |
| Nortriptyline | None | 11 | $90 | $8 |
| Sertraline | None | 14 | $76 | $5 |
| Promethazine | None | 20 | $66 | $3 |
| Diazepam | None | 13 | $43 | $3 |
| Mirtazapine | None | 12 | $29 | $2 |
Year by year
| 2024 | 2,955 | 486 | None | 13% | $912,513 |
| 2023 | 2,836 | 480 | None | 14% | $1,113,162 |
| 2022 | 2,931 | 457 | 0% (12) | 12% | $1,012,034 |
| 2021 | 2,575 | 439 | None | None | $613,531 |
| 2020 | 2,453 | 394 | None | None | $511,572 |
| 2019 | 2,607 | 412 | None | 9% | $730,354 |
| 2018 | 2,398 | 370 | 1% (22) | None | $526,374 |
| 2017 | 2,259 | 321 | 2% (47) | 7% | $640,001 |
| 2016 | 2,317 | 306 | 4% (85) | 7% | $518,465 |
| 2015 | 2,354 | 288 | 3% (67) | None | $525,388 |
| 2014 | 2,377 | 309 | 2% (37) | 11% | $465,655 |
| 2013 | 2,103 | 279 | 1% (29) | 15% | $425,710 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 63 drugs
| Gamunex-C | Immune globulin | 46 | $173,127 | $3,764 |
| Nurtec Odt | None | 63 | $140,547 | $2,231 |
| Avonex | None | 12 | $102,625 | $8,552 |
| Copaxone | None | 12 | $91,344 | $7,612 |
| Aimovig | Migraine | 88 | $86,061 | $978 |
| Austedo | None | 11 | $68,463 | $6,224 |
| Ubrelvy | None | 44 | $65,481 | $1,488 |
| Rytary | Parkinson's | 26 | $46,943 | $1,805 |
| Reyvow | None | 11 | $31,554 | $2,869 |
| Carbidopa-Levodopa | None | 269 | $22,733 | $85 |
| Neupro | None | 11 | $16,189 | $1,472 |
| Lacosamide | None | 16 | $16,173 | $1,011 |
| Dalfampridine Er | None | 19 | $14,394 | $758 |
| Sumatriptan | None | 122 | $13,269 | $109 |
| Levetiracetam | None | 197 | $12,125 | $62 |
| Emgality | Migraine | 11 | $8,780 | $798 |
| Oxcarbazepine | None | 29 | $8,168 | $282 |
| Propranolol Hcl Er | None | 85 | $7,854 | $92 |
| Carbidopa | None | 17 | $5,821 | $342 |
| Gabapentin | None | 233 | $5,134 | $22 |
| Ropinirole | None | 51 | $4,915 | $96 |
| Propranolol | None | 110 | $4,803 | $44 |
| Dilantin | None | 13 | $4,221 | $325 |
| Amantadine | None | 27 | $3,873 | $143 |
| Donepezil | None | 187 | $3,830 | $20 |
| Divalproex | None | 72 | $3,393 | $47 |
| Carbamazepine | None | 47 | $2,959 | $63 |
| Pyridostigmine | None | 12 | $2,792 | $233 |
| Topiramate | None | 24 | $2,750 | $115 |
| Baclofen | None | 52 | $2,458 | $47 |
| Eletriptan Hbr | None | 22 | $2,352 | $107 |
| Lamotrigine | None | 48 | $2,322 | $48 |
| Rivastigmine | None | 22 | $2,289 | $104 |
| Memantine | None | 53 | $2,167 | $41 |
| Carbamazepine Er | None | 17 | $1,970 | $116 |
| Donepezil Hcl Odt | None | 29 | $1,689 | $58 |
| Duloxetine | None | 25 | $1,496 | $60 |
| Primidone | None | 25 | $1,469 | $59 |
| Azathioprine | None | 19 | $1,338 | $70 |
| Olanzapine | None | 12 | $1,227 | $102 |
| Mycophenolate Mofetil | None | 13 | $1,108 | $85 |
| Naratriptan | None | 13 | $964 | $74 |
| Mirtazapine | None | 19 | $953 | $50 |
| Divalproex Sodium Er | None | 11 | $913 | $83 |
| Escitalopram | None | 32 | $884 | $28 |
| Oxybutynin Chloride Er | None | 15 | $725 | $48 |
| Zonisamide | None | 11 | $697 | $63 |
| Phenytoin Sodium Extended | None | 18 | $484 | $27 |
| Cyclobenzaprine | None | 16 | $434 | $27 |
| Quetiapine | None | 24 | $411 | $17 |
| Clopidogrel | None | 12 | $377 | $31 |
| Atorvastatin | None | 16 | $333 | $21 |
| Amitriptyline | None | 20 | $323 | $16 |
| Clonazepam | None | 18 | $310 | $17 |
| Rizatriptan | None | 14 | $278 | $20 |
| Sertraline | None | 14 | $230 | $16 |
| Nortriptyline | None | 13 | $216 | $17 |
| Trihexyphenidyl | None | 12 | $184 | $15 |
| Prednisone | None | 23 | $183 | $8 |
| Lorazepam | None | 23 | $175 | $8 |
| Ibuprofen | None | 11 | $157 | $14 |
| Ondansetron | None | 14 | $101 | $7 |
| Promethazine | None | 17 | $64 | $4 |
2022: 61 drugs
| Gamunex-C | Immune globulin | 17 | $155,519 | $9,148 |
| Nurtec Odt | None | 69 | $134,675 | $1,952 |
| Copaxone | None | 13 | $98,956 | $7,612 |
| Aimovig | Migraine | 80 | $93,930 | $1,174 |
| Rytary | Parkinson's | 42 | $78,249 | $1,863 |
| Dimethyl | None | 11 | $52,059 | $4,733 |
| Ubrelvy | None | 35 | $42,433 | $1,212 |
| Dalfampridine Er | None | 42 | $22,176 | $528 |
| Carbidopa-Levodopa | None | 254 | $21,821 | $86 |
| Neupro | None | 18 | $14,411 | $801 |
| Emgality | Migraine | 15 | $14,298 | $953 |
| Modafinil | None | 16 | $12,110 | $757 |
| Levetiracetam | None | 204 | $10,729 | $53 |
| Sumatriptan | None | 143 | $10,379 | $73 |
| Eletriptan Hbr | None | 33 | $10,350 | $314 |
| Gabapentin | None | 242 | $8,961 | $37 |
| Clorazepate Dipotassium | None | 13 | $7,981 | $614 |
| Pyridostigmine Bromide Er | None | 12 | $6,221 | $518 |
| Propranolol Hcl Er | None | 76 | $5,844 | $77 |
| Divalproex | None | 57 | $5,645 | $99 |
| Amantadine | None | 42 | $4,230 | $101 |
| Carbamazepine | None | 45 | $4,005 | $89 |
| Propranolol | None | 89 | $3,904 | $44 |
| Baclofen | None | 42 | $3,811 | $91 |
| Rivastigmine | None | 14 | $3,784 | $270 |
| Memantine | None | 65 | $3,636 | $56 |
| Dilantin | None | 12 | $3,584 | $299 |
| Rivastigmine | None | 20 | $3,461 | $173 |
| Zolmitriptan | None | 20 | $3,213 | $161 |
| Pyridostigmine | None | 15 | $2,955 | $197 |
| Divalproex Sodium Er | None | 12 | $2,853 | $238 |
| Donepezil | None | 178 | $2,725 | $15 |
| Ropinirole | None | 54 | $2,507 | $46 |
| Duloxetine | None | 22 | $2,296 | $104 |
| Lamotrigine | None | 52 | $2,125 | $41 |
| Olanzapine | None | 14 | $1,916 | $137 |
| Carbamazepine Er | None | 17 | $1,834 | $108 |
| Oxcarbazepine | None | 18 | $1,815 | $101 |
| Donepezil Hcl Odt | None | 39 | $1,783 | $46 |
| Mirtazapine | None | 20 | $1,466 | $73 |
| Escitalopram | None | 37 | $1,084 | $29 |
| Primidone | None | 30 | $1,001 | $33 |
| Topiramate | None | 25 | $898 | $36 |
| Pregabalin | None | 13 | $812 | $62 |
| Quetiapine | None | 47 | $776 | $17 |
| Oxybutynin Chloride Er | None | 13 | $691 | $53 |
| Zonisamide | None | 12 | $681 | $57 |
| Phenytoin Sodium Extended | None | 26 | $675 | $26 |
| Cyclobenzaprine | None | 16 | $593 | $37 |
| Mycophenolate Mofetil | None | 18 | $591 | $33 |
| Nortriptyline | None | 32 | $578 | $18 |
| Clonazepam | None | 21 | $525 | $25 |
| Azathioprine | None | 11 | $493 | $45 |
| Prednisone | None | 33 | $433 | $13 |
| Rizatriptan | None | 14 | $427 | $30 |
| Atorvastatin | None | 15 | $315 | $21 |
| Trihexyphenidyl | None | 21 | $315 | $15 |
| Clopidogrel | None | 15 | $297 | $20 |
| Amitriptyline | None | 13 | $293 | $23 |
| Lorazepam | None | 25 | $85 | $3 |
| Promethazine | None | 19 | $80 | $4 |
2021: 49 drugs
| Aimovig | Migraine | 93 | $80,482 | $865 |
| Ubrelvy | None | 51 | $58,958 | $1,156 |
| Rytary | Parkinson's | 35 | $44,327 | $1,266 |
| Carbidopa-Levodopa | None | 240 | $21,354 | $89 |
| Dalfampridine Er | None | 23 | $11,523 | $501 |
| Sumatriptan | None | 152 | $11,446 | $75 |
| Levetiracetam | None | 169 | $10,825 | $64 |
| Neupro | None | 13 | $10,430 | $802 |
| Modafinil | None | 18 | $8,342 | $463 |
| Gabapentin | None | 212 | $8,166 | $39 |
| Ajovy | None | 11 | $6,561 | $596 |
| Divalproex | None | 54 | $6,367 | $118 |
| Amantadine | None | 48 | $6,071 | $126 |
| Propranolol Hcl Er | None | 56 | $5,358 | $96 |
| Pyridostigmine Bromide Er | None | 11 | $5,059 | $460 |
| Memantine | None | 65 | $3,833 | $59 |
| Pyridostigmine | None | 15 | $3,602 | $240 |
| Dilantin | None | 12 | $3,402 | $283 |
| Rivastigmine | None | 30 | $3,360 | $112 |
| Carbamazepine Er | None | 27 | $3,209 | $119 |
| Zonisamide | None | 26 | $2,891 | $111 |
| Propranolol | None | 66 | $2,759 | $42 |
| Carbamazepine | None | 41 | $2,736 | $67 |
| Donepezil | None | 177 | $2,557 | $14 |
| Baclofen | None | 21 | $2,378 | $113 |
| Primidone | None | 24 | $1,969 | $82 |
| Ropinirole | None | 48 | $1,752 | $37 |
| Donepezil Hcl Odt | None | 36 | $1,725 | $48 |
| Zolmitriptan | None | 16 | $1,704 | $107 |
| Lamotrigine | None | 52 | $1,665 | $32 |
| Carbidopa-Levodopa Er | None | 17 | $1,544 | $91 |
| Oxcarbazepine | None | 15 | $1,501 | $100 |
| Oxybutynin Chloride Er | None | 18 | $1,439 | $80 |
| Phenytoin Sodium Extended | None | 25 | $970 | $39 |
| Duloxetine | None | 17 | $853 | $50 |
| Nortriptyline | None | 49 | $844 | $17 |
| Topiramate | None | 28 | $675 | $24 |
| Rizatriptan | None | 16 | $669 | $42 |
| Cyclobenzaprine | None | 16 | $394 | $25 |
| Clopidogrel | None | 18 | $366 | $20 |
| Clonazepam | None | 26 | $353 | $14 |
| Escitalopram | None | 47 | $349 | $7 |
| Mycophenolate Mofetil | None | 11 | $330 | $30 |
| Amitriptyline | None | 15 | $293 | $20 |
| Prednisone | None | 19 | $165 | $9 |
| Trihexyphenidyl | None | 14 | $114 | $8 |
| Lorazepam | None | 26 | $99 | $4 |
| Ibuprofen | None | 11 | $86 | $8 |
| Promethazine | None | 11 | $81 | $7 |
2020: 51 drugs
| Glatiramer Acetate | None | 26 | $106,379 | $4,092 |
| Aimovig | Migraine | 116 | $88,194 | $760 |
| Banzel | None | 11 | $43,896 | $3,991 |
| Carbidopa-Levodopa | None | 252 | $20,424 | $81 |
| Dalfampridine Er | None | 23 | $10,983 | $478 |
| Carbamazepine Er | None | 54 | $10,104 | $187 |
| Sumatriptan | None | 18 | $9,413 | $523 |
| Gabapentin | None | 232 | $8,719 | $38 |
| Levetiracetam | None | 151 | $7,830 | $52 |
| Sumatriptan | None | 129 | $6,888 | $53 |
| Rasagiline Mesylate | None | 11 | $6,316 | $574 |
| Amantadine | None | 39 | $4,190 | $107 |
| Pyridostigmine Bromide Er | None | 12 | $4,160 | $347 |
| Memantine | None | 46 | $4,083 | $89 |
| Carbamazepine | None | 46 | $4,037 | $88 |
| Dilantin | None | 12 | $3,208 | $267 |
| Modafinil | None | 14 | $2,906 | $208 |
| Pyridostigmine | None | 18 | $2,825 | $157 |
| Rivastigmine | None | 28 | $2,738 | $98 |
| Donepezil | None | 195 | $2,628 | $13 |
| Lidocaine | None | 13 | $2,485 | $191 |
| Carbidopa-Levodopa Er | None | 22 | $2,384 | $108 |
| Clorazepate Dipotassium | None | 11 | $2,357 | $214 |
| Ropinirole | None | 48 | $2,269 | $47 |
| Propranolol Hcl Er | None | 44 | $2,134 | $49 |
| Baclofen | None | 30 | $1,787 | $60 |
| Oxybutynin Chloride Er | None | 13 | $1,770 | $136 |
| Lamotrigine | None | 58 | $1,552 | $27 |
| Primidone | None | 24 | $1,432 | $60 |
| Phenytoin Sodium Extended | None | 29 | $1,236 | $43 |
| Pramipexole Dihydrochloride | None | 16 | $1,227 | $77 |
| Pregabalin | None | 13 | $1,222 | $94 |
| Divalproex | None | 39 | $1,160 | $30 |
| Oxcarbazepine | None | 13 | $939 | $72 |
| Propranolol | None | 40 | $884 | $22 |
| Clonazepam | None | 32 | $825 | $26 |
| Topiramate | None | 37 | $764 | $21 |
| Zonisamide | None | 23 | $753 | $33 |
| Duloxetine | None | 12 | $555 | $46 |
| Rizatriptan | None | 21 | $487 | $23 |
| Nortriptyline | None | 43 | $460 | $11 |
| Bupropion Hcl Sr | None | 14 | $392 | $28 |
| Donepezil Hcl Odt | None | 21 | $377 | $18 |
| Cyclobenzaprine | None | 22 | $322 | $15 |
| Mycophenolate Mofetil | None | 12 | $282 | $24 |
| Amitriptyline | None | 11 | $240 | $22 |
| Ibuprofen | None | 15 | $182 | $12 |
| Prednisone | None | 16 | $128 | $8 |
| Lorazepam | None | 23 | $103 | $4 |
| Escitalopram | None | 25 | $88 | $4 |
| Trihexyphenidyl | None | 13 | $82 | $6 |
2019: 54 drugs
| Glatiramer Acetate | None | 21 | $92,477 | $4,404 |
| Tecfidera | None | 12 | $92,284 | $7,690 |
| Avonex | None | 12 | $83,979 | $6,998 |
| Aimovig | Migraine | 65 | $43,814 | $674 |
| Dalfampridine Er | None | 32 | $40,393 | $1,262 |
| Carbidopa-Levodopa | None | 275 | $16,113 | $59 |
| Lyrica | None | 17 | $14,780 | $869 |
| Rasagiline Mesylate | None | 17 | $11,006 | $647 |
| Sumatriptan | None | 121 | $8,536 | $71 |
| Gabapentin | None | 275 | $8,296 | $30 |
| Carbamazepine Er | None | 49 | $8,256 | $168 |
| Levetiracetam | None | 154 | $4,944 | $32 |
| Amantadine | None | 34 | $4,899 | $144 |
| Clorazepate Dipotassium | None | 13 | $3,932 | $302 |
| Sumatriptan | None | 13 | $3,900 | $300 |
| Mycophenolate Mofetil | None | 11 | $3,598 | $327 |
| Rivastigmine | None | 41 | $3,309 | $81 |
| Modafinil | None | 14 | $3,169 | $226 |
| Donepezil | None | 219 | $3,160 | $14 |
| Carbamazepine | None | 44 | $2,923 | $66 |
| Dilantin | None | 11 | $2,821 | $256 |
| Memantine | None | 52 | $2,791 | $54 |
| Eletriptan Hbr | None | 11 | $2,642 | $240 |
| Lamotrigine | None | 87 | $1,988 | $23 |
| Primidone | None | 27 | $1,937 | $72 |
| Propranolol Hcl Er | None | 36 | $1,889 | $52 |
| Carbidopa-Levodopa Er | None | 18 | $1,793 | $100 |
| Ropinirole | None | 56 | $1,562 | $28 |
| Dilantin | None | 12 | $1,290 | $108 |
| Phenytoin Sodium Extended | None | 46 | $1,269 | $28 |
| Baclofen | None | 28 | $1,254 | $45 |
| Propranolol | None | 58 | $1,159 | $20 |
| Pramipexole Dihydrochloride | None | 11 | $1,158 | $105 |
| Duloxetine | None | 17 | $987 | $58 |
| Pregabalin | None | 11 | $913 | $83 |
| Oxcarbazepine | None | 19 | $651 | $34 |
| Clonazepam | None | 56 | $572 | $10 |
| Divalproex | None | 29 | $543 | $19 |
| Zonisamide | None | 19 | $505 | $27 |
| Topiramate | None | 41 | $480 | $12 |
| Donepezil Hcl Odt | None | 16 | $369 | $23 |
| Rizatriptan | None | 18 | $353 | $20 |
| Quetiapine | None | 22 | $323 | $15 |
| Cyclobenzaprine | None | 30 | $197 | $7 |
| Lorazepam | None | 38 | $148 | $4 |
| Nortriptyline | None | 18 | $146 | $8 |
| Escitalopram | None | 12 | $133 | $11 |
| Ondansetron Odt | None | 11 | $132 | $12 |
| Clopidogrel | None | 12 | $108 | $9 |
| Trihexyphenidyl | None | 15 | $66 | $4 |
| Sertraline | None | 11 | $63 | $6 |
| Prednisone | None | 12 | $61 | $5 |
| Promethazine | None | 13 | $58 | $4 |
| Trazodone | None | 13 | $56 | $4 |
2018: 54 drugs
| Avonex | None | 12 | $82,577 | $6,881 |
| Ampyra | None | 12 | $31,954 | $2,663 |
| Lyrica | None | 19 | $15,674 | $825 |
| Carbidopa-Levodopa | None | 264 | $13,329 | $50 |
| Sumatriptan | None | 129 | $12,428 | $96 |
| Rasagiline Mesylate | None | 15 | $11,599 | $773 |
| Aimovig | Migraine | 16 | $9,828 | $614 |
| Sumatriptan | None | 16 | $7,921 | $495 |
| Carbamazepine Er | None | 57 | $7,368 | $129 |
| Pyridostigmine | None | 24 | $5,684 | $237 |
| Gabapentin | None | 226 | $5,059 | $22 |
| Amantadine | None | 28 | $3,763 | $134 |
| Levetiracetam | None | 140 | $3,136 | $22 |
| Dilantin | None | 12 | $2,979 | $248 |
| Propranolol Hcl Er | None | 25 | $2,946 | $118 |
| Donepezil | None | 212 | $2,841 | $13 |
| Clorazepate Dipotassium | None | 12 | $2,578 | $215 |
| Duloxetine | None | 30 | $2,409 | $80 |
| Modafinil | None | 14 | $2,386 | $170 |
| Eletriptan Hbr | None | 11 | $2,367 | $215 |
| Carbamazepine | None | 29 | $2,026 | $70 |
| Memantine | None | 33 | $1,805 | $55 |
| Dilantin | None | 18 | $1,362 | $76 |
| Lamotrigine | None | 49 | $1,358 | $28 |
| Oxybutynin Chloride Er | None | 12 | $1,336 | $111 |
| Pramipexole Dihydrochloride | None | 30 | $1,275 | $42 |
| Rivastigmine | None | 26 | $1,244 | $48 |
| Ropinirole | None | 47 | $1,229 | $26 |
| Phenytoin Sodium Extended | None | 53 | $1,207 | $23 |
| Propranolol | None | 57 | $1,147 | $20 |
| Baclofen | None | 27 | $1,124 | $42 |
| Dextroamphetamine-Amphetamine | None | 16 | $1,059 | $66 |
| Topiramate | None | 54 | $1,053 | $19 |
| Carbidopa-Levodopa Er | None | 13 | $763 | $59 |
| Oxcarbazepine | None | 12 | $653 | $54 |
| Voltaren | None | 11 | $604 | $55 |
| Bupropion Hcl Sr | None | 12 | $564 | $47 |
| Divalproex | None | 35 | $478 | $14 |
| Primidone | None | 13 | $420 | $32 |
| Zonisamide | None | 16 | $383 | $24 |
| Clonazepam | None | 47 | $367 | $8 |
| Nortriptyline | None | 26 | $268 | $10 |
| Clopidogrel | None | 18 | $262 | $15 |
| Rizatriptan | None | 14 | $260 | $19 |
| Donepezil Hcl Odt | None | 11 | $191 | $17 |
| Amitriptyline | None | 13 | $176 | $14 |
| Sertraline | None | 39 | $171 | $4 |
| Prednisone | None | 19 | $121 | $6 |
| Tramadol | None | 13 | $114 | $9 |
| Lorazepam | None | 30 | $104 | $3 |
| Ondansetron Odt | None | 12 | $86 | $7 |
| Trazodone | None | 26 | $80 | $3 |
| Escitalopram | None | 12 | $58 | $5 |
| Cyclobenzaprine | None | 23 | $47 | $2 |
2017: 52 drugs
| Tecfidera | 17 | $186,624 | $10,978 |
| Tetrabenazine | 11 | $179,560 | $16,324 |
| Avonex | 11 | $70,463 | $6,406 |
| Ampyra | 13 | $29,633 | $2,279 |
| Rasagiline Mesylate | 14 | $10,540 | $753 |
| Lyrica | 13 | $8,771 | $675 |
| Carbidopa-Levodopa | 219 | $8,051 | $37 |
| Sumatriptan | 102 | $7,651 | $75 |
| Carbamazepine Er | 54 | $7,338 | $136 |
| Sumatriptan | 16 | $6,108 | $382 |
| Gabapentin | 259 | $5,535 | $21 |
| Pyridostigmine | 16 | $4,821 | $301 |
| Modafinil | 18 | $4,359 | $242 |
| Levetiracetam | 157 | $3,183 | $20 |
| Carbamazepine | 33 | $2,854 | $86 |
| Amantadine | 28 | $2,713 | $97 |
| Propranolol Hcl Er | 23 | $2,632 | $114 |
| Dilantin | 12 | $2,410 | $201 |
| Clorazepate Dipotassium | 11 | $2,370 | $215 |
| Donepezil | 191 | $2,360 | $12 |
| Oxybutynin Chloride Er | 28 | $1,780 | $64 |
| Duloxetine | 33 | $1,583 | $48 |
| Baclofen | 27 | $1,434 | $53 |
| Propranolol | 49 | $1,415 | $29 |
| Rivastigmine | 16 | $1,345 | $84 |
| Pramipexole Dihydrochloride | 24 | $1,258 | $52 |
| Phenytoin Sodium Extended | 47 | $1,204 | $26 |
| Divalproex Sodium Er | 25 | $1,134 | $45 |
| Dilantin | 15 | $1,003 | $67 |
| Lamotrigine | 57 | $797 | $14 |
| Carbidopa-Levodopa Er | 17 | $763 | $45 |
| Ropinirole | 28 | $704 | $25 |
| Dextroamphetamine-Amphetamine | 11 | $605 | $55 |
| Topiramate | 58 | $557 | $10 |
| Amitriptyline | 21 | $539 | $26 |
| Memantine | 12 | $427 | $36 |
| Clonazepam | 48 | $426 | $9 |
| Clopidogrel | 25 | $312 | $12 |
| Primidone | 12 | $311 | $26 |
| Tizanidine | 13 | $304 | $23 |
| Phenobarbital | 12 | $300 | $25 |
| Hydrocodone-Acetaminophen | 18 | $234 | $13 |
| Nortriptyline | 23 | $218 | $9 |
| Divalproex | 17 | $207 | $12 |
| Quetiapine | 11 | $143 | $13 |
| Diazepam | 19 | $126 | $7 |
| Ondansetron Odt | 12 | $98 | $8 |
| Sertraline | 24 | $92 | $4 |
| Cyclobenzaprine | 20 | $80 | $4 |
| Tramadol | 24 | $77 | $3 |
| Prednisone | 13 | $56 | $4 |
| Lorazepam | 21 | $32 | $2 |
2016: 55 drugs
| Tetrabenazine | 12 | $198,664 | $16,555 |
| Tecfidera | 16 | $129,295 | $8,081 |
| Ampyra | 13 | $26,572 | $2,044 |
| Azilect | 18 | $15,633 | $868 |
| Sumatriptan | 64 | $11,735 | $183 |
| Relpax | 11 | $9,027 | $821 |
| Gabapentin | 332 | $6,874 | $21 |
| Carbidopa-Levodopa | 200 | $6,788 | $34 |
| Carbamazepine Er | 43 | $5,723 | $133 |
| Lidocaine | 12 | $4,507 | $376 |
| Pyridostigmine | 20 | $3,800 | $190 |
| Amantadine | 33 | $3,076 | $93 |
| Rivastigmine | 20 | $3,036 | $152 |
| Modafinil | 11 | $2,768 | $252 |
| Tegretol Xr | 11 | $2,698 | $245 |
| Carbamazepine | 30 | $2,690 | $90 |
| Selegiline | 27 | $2,663 | $99 |
| Propranolol Hcl Er | 18 | $2,561 | $142 |
| Levetiracetam | 124 | $2,483 | $20 |
| Dilantin | 12 | $2,183 | $182 |
| Donepezil | 181 | $2,179 | $12 |
| Propranolol | 46 | $1,871 | $41 |
| Divalproex Sodium Er | 30 | $1,804 | $60 |
| Oxybutynin Chloride Er | 26 | $1,521 | $58 |
| Pramipexole Dihydrochloride | 31 | $1,487 | $48 |
| Baclofen | 51 | $1,400 | $27 |
| Phenytoin Sodium Extended | 39 | $1,127 | $29 |
| Dextroamphetamine-Amphetamine | 15 | $1,115 | $74 |
| Acetaminophen-Codeine | 16 | $1,013 | $63 |
| Carbidopa-Levodopa Er | 23 | $999 | $43 |
| Dilantin | 13 | $897 | $69 |
| Lamotrigine | 63 | $872 | $14 |
| Topiramate | 57 | $843 | $15 |
| Hydrocodone-Acetaminophen | 32 | $765 | $24 |
| Ropinirole | 29 | $691 | $24 |
| Primidone | 28 | $662 | $24 |
| Tizanidine | 28 | $627 | $22 |
| Divalproex | 30 | $518 | $17 |
| Duloxetine | 13 | $463 | $36 |
| Phenobarbital | 12 | $426 | $36 |
| Quetiapine | 21 | $358 | $17 |
| Clopidogrel | 30 | $351 | $12 |
| Tramadol | 31 | $301 | $10 |
| Nortriptyline | 33 | $281 | $9 |
| Clonazepam | 46 | $266 | $6 |
| Ibuprofen | 12 | $196 | $16 |
| Temazepam | 12 | $189 | $16 |
| Venlafaxine Hcl Er | 13 | $120 | $9 |
| Diazepam | 23 | $98 | $4 |
| Prednisone | 15 | $77 | $5 |
| Promethazine | 11 | $63 | $6 |
| Trihexyphenidyl | 12 | $50 | $4 |
| Lorazepam | 32 | $50 | $2 |
| Fluoxetine | 22 | $43 | $2 |
| Cyclobenzaprine | 12 | $18 | $2 |
2015: 53 drugs
| Tecfidera | 22 | $119,069 | $5,412 |
| Azilect | 28 | $18,461 | $659 |
| Banzel | 11 | $9,798 | $891 |
| Gabapentin | 326 | $6,371 | $20 |
| Sumatriptan | 79 | $6,239 | $79 |
| Carbidopa-Levodopa | 180 | $5,994 | $33 |
| Carbidopa-Levodopa-Entacapone | 13 | $5,615 | $432 |
| Modafinil | 11 | $5,462 | $497 |
| Carbamazepine | 33 | $3,544 | $107 |
| Pyridostigmine | 15 | $3,331 | $222 |
| Lyrica | 15 | $3,047 | $203 |
| Tegretol Xr | 11 | $2,933 | $267 |
| Pramipexole Dihydrochloride | 33 | $2,905 | $88 |
| Carbamazepine Er | 25 | $2,689 | $108 |
| Selegiline | 18 | $2,201 | $122 |
| Propranolol Hcl Er | 25 | $2,154 | $86 |
| Levetiracetam | 103 | $1,824 | $18 |
| Dilantin | 12 | $1,776 | $148 |
| Divalproex Sodium Er | 25 | $1,703 | $68 |
| Donepezil | 162 | $1,615 | $10 |
| Duloxetine | 12 | $1,586 | $132 |
| Propranolol | 58 | $1,512 | $26 |
| Phenytoin Sodium Extended | 40 | $1,354 | $34 |
| Ropinirole | 49 | $1,284 | $26 |
| Amantadine | 14 | $1,139 | $81 |
| Baclofen | 40 | $1,071 | $27 |
| Lamotrigine | 61 | $1,063 | $17 |
| Oxybutynin Chloride Er | 16 | $997 | $62 |
| Primidone | 35 | $899 | $26 |
| Dilantin | 19 | $880 | $46 |
| Divalproex | 32 | $878 | $27 |
| Dextroamphetamine-Amphetamine | 12 | $790 | $66 |
| Topiramate | 57 | $786 | $14 |
| Nortriptyline | 65 | $601 | $9 |
| Acetaminophen-Codeine | 15 | $550 | $37 |
| Hydrocodone-Acetaminophen | 23 | $492 | $21 |
| Clonazepam | 61 | $481 | $8 |
| Tizanidine | 15 | $452 | $30 |
| Venlafaxine Hcl Er | 18 | $394 | $22 |
| Clopidogrel | 50 | $392 | $8 |
| Carbidopa-Levodopa Er | 22 | $345 | $16 |
| Escitalopram | 19 | $248 | $13 |
| Tramadol | 22 | $243 | $11 |
| Quetiapine | 17 | $221 | $13 |
| Amitriptyline | 12 | $199 | $17 |
| Prednisone | 16 | $199 | $12 |
| Sertraline | 18 | $195 | $11 |
| Temazepam | 12 | $179 | $15 |
| Trihexyphenidyl | 13 | $104 | $8 |
| Simvastatin | 18 | $88 | $5 |
| Fluoxetine | 25 | $69 | $3 |
| Lorazepam | 26 | $51 | $2 |
| Cyclobenzaprine | 12 | $18 | $1 |
2014: 54 drugs
| Xenazine | 12 | $175,280 | $14,607 |
| Tecfidera | 14 | $108,191 | $7,728 |
| Azilect | 27 | $16,473 | $610 |
| Namenda | 25 | $12,150 | $486 |
| Lidocaine | 27 | $9,256 | $343 |
| Gabapentin | 349 | $8,855 | $25 |
| Vimpat | 12 | $6,753 | $563 |
| Carbidopa-Levodopa | 178 | $6,648 | $37 |
| Topamax | 11 | $5,283 | $480 |
| Carbidopa-Levodopa-Entacapone | 13 | $5,156 | $397 |
| Tegretol Xr | 27 | $4,826 | $179 |
| Entacapone | 11 | $4,799 | $436 |
| Lyrica | 19 | $4,001 | $211 |
| Levetiracetam | 114 | $3,555 | $31 |
| Selegiline | 25 | $3,300 | $132 |
| Duloxetine | 16 | $3,189 | $199 |
| Carbamazepine | 42 | $3,052 | $73 |
| Ropinirole | 63 | $2,785 | $44 |
| Divalproex Sodium Er | 16 | $2,543 | $159 |
| Donepezil | 151 | $2,099 | $14 |
| Pyridostigmine | 17 | $2,054 | $121 |
| Sumatriptan | 51 | $1,916 | $38 |
| Pramipexole Dihydrochloride | 21 | $1,848 | $88 |
| Lamotrigine | 47 | $1,573 | $33 |
| Propranolol Hcl Er | 16 | $1,488 | $93 |
| Mycophenolate Mofetil | 11 | $1,479 | $134 |
| Oxybutynin Chloride Er | 27 | $1,332 | $49 |
| Topiramate | 71 | $1,091 | $15 |
| Dilantin | 31 | $1,090 | $35 |
| Venlafaxine Hcl Er | 30 | $1,088 | $36 |
| Phenytoin Sodium Extended | 38 | $1,081 | $28 |
| Divalproex | 48 | $976 | $20 |
| Carbamazepine Er | 11 | $831 | $76 |
| Nortriptyline | 72 | $779 | $11 |
| Baclofen | 37 | $698 | $19 |
| Primidone | 19 | $670 | $35 |
| Propafenone | 11 | $637 | $58 |
| Propranolol | 69 | $610 | $9 |
| Quetiapine | 12 | $600 | $50 |
| Clopidogrel | 38 | $407 | $11 |
| Carbidopa-Levodopa Er | 26 | $361 | $14 |
| Cyclobenzaprine | 14 | $291 | $21 |
| Indomethacin | 14 | $228 | $16 |
| Escitalopram | 15 | $211 | $14 |
| Temazepam | 17 | $195 | $11 |
| Hydrocodone-Acetaminophen | 14 | $184 | $13 |
| Clonazepam | 27 | $169 | $6 |
| Fluoxetine | 35 | $143 | $4 |
| Ibuprofen | 11 | $143 | $13 |
| Simvastatin | 19 | $131 | $7 |
| Lorazepam | 29 | $107 | $4 |
| Amitriptyline | 11 | $101 | $9 |
| Citalopram Hbr | 12 | $93 | $8 |
| Prednisone | 14 | $82 | $6 |
2013: 45 drugs
| Xenazine | 14 | $183,908 | $13,136 |
| Copaxone | 14 | $66,469 | $4,748 |
| Namenda | 55 | $21,461 | $390 |
| Modafinil | 26 | $15,337 | $590 |
| Azilect | 28 | $13,826 | $494 |
| Gabapentin | 304 | $9,690 | $32 |
| Lyrica | 17 | $5,986 | $352 |
| Lidoderm | 13 | $5,442 | $419 |
| Relpax | 11 | $5,193 | $472 |
| Carbidopa-Levodopa | 122 | $4,997 | $41 |
| Tegretol Xr | 31 | $4,681 | $151 |
| Levetiracetam | 98 | $4,266 | $44 |
| Selegiline | 24 | $3,751 | $156 |
| Donepezil | 170 | $2,986 | $18 |
| Ropinirole | 45 | $2,711 | $60 |
| Carbamazepine Xr | 14 | $2,198 | $157 |
| Topiramate | 73 | $1,830 | $25 |
| Amantadine | 11 | $1,721 | $156 |
| Oxcarbazepine | 21 | $1,592 | $76 |
| Lamotrigine | 60 | $1,452 | $24 |
| Divalproex | 62 | $1,331 | $21 |
| Donepezil Hcl Odt | 12 | $1,328 | $111 |
| Carbamazepine | 40 | $1,316 | $33 |
| Sumatriptan | 42 | $1,287 | $31 |
| Pyridostigmine | 12 | $1,258 | $105 |
| Mycophenolate Mofetil | 12 | $1,135 | $95 |
| Quetiapine | 22 | $1,133 | $52 |
| Oxybutynin Chloride Er | 15 | $886 | $59 |
| Carbamazepine Er | 12 | $833 | $69 |
| Phenytoin Sodium Extended | 32 | $832 | $26 |
| Propafenone | 12 | $748 | $62 |
| Clopidogrel | 48 | $715 | $15 |
| Propranolol | 55 | $713 | $13 |
| Dilantin | 23 | $655 | $28 |
| Primidone | 23 | $648 | $28 |
| Venlafaxine Hcl Er | 22 | $568 | $26 |
| Nortriptyline | 56 | $530 | $9 |
| Carbidopa-Levodopa Er | 32 | $500 | $16 |
| Baclofen | 13 | $281 | $22 |
| Lorazepam | 36 | $197 | $5 |
| Clonazepam | 25 | $173 | $7 |
| Fluoxetine | 18 | $155 | $9 |
| Temazepam | 14 | $111 | $8 |
| Cyclobenzaprine | 19 | $96 | $5 |
| Zolpidem | 11 | $77 | $7 |
Money from drug and device companies
$462 in 2025
| 2025 | 3 | 13 | None | $462 |
| 2024 | 5 | 5 | None | $388 |
| 2023 | 2 | 3 | None | $80 |
| 2022 | 3 | 5 | None | $309 |
| 2021 | 2 | 3 | None | $128 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Vyalev | $284 | 10 payments
|
| Neurocrine BioSciences | Ingrezza | $126 | 1 payment
|
| SK Life Science | None | $52 | 2 payments
|
See all 13 published payments
| SK Life Science | Meals · 2025-12-04 | None | $30 |
| Abbvie | Meals · 2025-12-02 | Vyalev | $109 |
| Abbvie | Meals · 2025-11-19 | Botox | $16 |
| Abbvie | Meals · 2025-11-03 | Vyalev | $26 |
| Abbvie | Meals · 2025-10-21 | Vyalev | $18 |
| Abbvie | Meals · 2025-09-30 | Vyalev | $20 |
| Abbvie | Meals · 2025-09-10 | Botox | $15 |
| Abbvie | Meals · 2025-09-04 | Qulipta | $9 |
| Abbvie | Meals · 2025-08-21 | Vyalev | $25 |
| Neurocrine BioSciences | Meals · 2025-07-17 | Ingrezza | $126 |
| Abbvie | Meals · 2025-06-24 | Botox | $11 |
| SK Life Science | Meals · 2025-04-02 | None | $22 |
| Abbvie | Meals · 2025-03-25 | Botox | $33 |
See earlier years (2024, 2023, 2022, 2021)
2024: $388
| Eisai | Leqembi | $125 | 1 payment
|
| SK Life Science | Xcopri | $108 | 1 payment
|
| Boston Scientific | None | $98 | 1 payment
|
| Abbvie | Botox | $29 | 1 payment
|
| Mitsubishi Tanabe Pharma America | Radicava | $28 | 1 payment
|
2023: $80
| AbbVie | Botox | $63 | 2 payments
|
| Boston Scientific | None | $17 | 1 payment
|
2022: $309
| Abbvie | Botox | $190 | 3 payments
|
| Boston Scientific | General - Dbs | $107 | 1 payment
|
| Impel Pharmaceuticals | Trudhesa | $12 | 1 payment
|
2021: $128
| Boston Scientific | General Dbs | $115 | 2 payments
|
| Zogenix | Fintepla | $13 | 1 payment
|
Professional record
- NPI
- 1417936568
- Licence
- CA A88363California A88363: Current · expires 2028-06-30
- Trained
- Tufts University School of Medicine, 1999
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Neurology (2084N0400X)
- Mailing address
- 2025 Soquel Ave, Santa Cruz, CA, 95062
- NPI first listed
- 2006-01-16
- NPI last updated
- 2012-01-30
This is when the NPI record was last certified, not a medical board exam.